Table 1.
Retrospective group |
Prospective group |
|||
Without Mt or Ms | Total | Without Mt or Ms | With Mt or Ms | |
Cases | 120 | 76 | 58 | 18 |
Age (yr) | 49.6 ± 11.5 | 50.8 ± 11.4 | 52.4 ± 11.0 | 45.4 ± 11.2 |
(30-81) | (24-78) | (31-78) | (24-65) | |
Sex (male/female) | 100/20 | 63/13 | 47/11 | 16/2 |
TBIL (μmol/L) | 12.8 ± 4.9 | 13.1 ± 4.5 | 11.9 ± 5.8 | |
PALB (mg/L) | 219 ± 59 | 222 ± 59 | 208 ± 58 | |
PT (s) | 12.5 ± 1.1 | 12.5 ± 1.0 | 12.6 ± 1.2 | |
HBsAg (+) | 98 (81.7%) | 65 (85.5%) | 49 (84.5%) | 16 (88.9%) |
Liver cirrhosis or fibrosis | 103 (85.8%) | 76 (100%) | 58 (100%) | 18 (100%) |
Size of tumor (mm) | 58.4 ± 42.6 | 54.9 ± 35.2 | 43.4 ± 23.9 | 92.0 ± 40.6 |
Tumor volume (cm3) | 107 ± 203 | 54 ± 111 | 275 ± 320 |
Mt: macroscopic tumor thrombus; Ms: macrosatellite. TBIL: total bilirubin; PALB: pre-albumin; PT: prothrombin time.